New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Utility of narrow band imaging in predicting histology in celiac disease.
Utility of narrow band imaging in predicting histology in celiac disease. Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology Sinha, S. K., Berry, N., Muktesh, G., Siddappa, P., Basha, J., Prasad, K., Appasani, S., Ashat, M., Vaiphei, K., Singh, K., Kochhar, R. 2020; 39 (4): 370-376Abstract
Narrow band imaging (NBI) with magnification better visualizes the duodenal microsurface and mucosal vascularity. NBI delineates villous atrophy better than conventional white light endoscopy.This study was conducted to evaluate the diagnostic accuracy of narrow band imaging with magnification (NBI-ME) in celiac disease (CD).In this prospective study, consecutive patients of suspected CD and controls were subjected to tissue transglutaminase antibody test and endoscopic evaluation initially with white light followed by NBI-ME, and biopsies were taken from duodenum. Duodenal villous patterns on NBI were interpreted as normal, blunted distorted, and absent. Severity of villous atrophy was reported according to the modified Marsh criteria.One hundred and twenty-two patients (mean age of 27.53?±?13.37 years and a male to female ratio of 1:1.26) and 40 controls were studied. The sensitivity and specificity of NBI-ME in predicting villous atrophy were found to be 95.54% and 90%, respectively. The specificity and negative predictive value of NBI-ME in predicting villous atrophy amongst controls was 100% and 97.5%, respectively. Abnormal findings (blunted and absent villous patterns) combined with elevated transglutaminase antibody (>?5-fold) were found to have high accuracy in predicting villous atrophy.NBI with magnification has high sensitivity and specificity in predicting villous atrophy in patients with celiac disease.
View details for DOI 10.1007/s12664-020-01030-1
View details for PubMedID 32705418